NEWSROOM

Learn more about our work, our members and our commitment to curing pediatric cancer.

For press inquiries, please contact press@cureworks.org

Seattle Children’s launches into solid tumor treatments with new CAR T immunotherapy trial

Seattle Children’s Research Institute is launching a clinical trial that will examine a new kind of cancer-fighting treatment. The treatment is a type of CAR T immunotherapy, which reprograms a person’s immune cells to find and destroy cancer.

READ MORE

 

Seattle Children’s launches CureWorks, a project aimed at revolutionizing cancer treatment for kids

New cancer immunotherapies could revolutionize how we treat the disease, but for many children, those treatments are far out of reach.

READ MORE

 

Seattle Children's Hospital launches immunotherapy collaborative to expand clinical trial access at children's hospitals

Four academic children's hospitals have joined forces to create a research collaborative that will make it easier for their patients to access immunotherapy clinical trials and for their researchers to find good candidates for therapies.

READ MORE

 

BC Children’s Hospital joins international collaborative to further the development of innovative immunotherapy treatments for kids with hard-to-treat cancer

Vancouver, BC — BC Children’s Hospital has joined CureWorks, an international collaborative of leading academic children’s hospitals focused on improving care for children with hard-to-treat cancers by expanding clinical trials and accelerating the development of leading-edge immunotherapy treatments.

READ MORE

 

 

 

For information about clinical trials in your area, please contact your child’s physician or visit clinicaltrials.gov

CureWorks™ is a trademark of Seattle Children’s
Healthcare System and its related and controlled organizations.
Copyright © 2018 Seattle Children’s Healthcare System.

Read the latest announcements

about our collaboration.

NEWSROOM

Learn more about our work, our members and our commitment to curing pediatric cancer.

For press inquiries, please contact press@cureworks.org

Seattle Children’s launches into solid tumor treatments with new CAR T immunotherapy trial

Seattle Children’s Research Institute is launching a clinical trial that will examine a new kind of cancer-fighting treatment. The treatment is a type of CAR T immunotherapy, which reprograms a person’s immune cells to find and destroy cancer.

READ MORE

 

Seattle Children’s launches CureWorks, a project aimed at revolutionizing cancer treatment for kids

New cancer immunotherapies could revolutionize how we treat the disease, but for many children, those treatments are far out of reach.

READ MORE

 

Seattle Children's Hospital launches immunotherapy collaborative to expand clinical trial access at children's hospitals

Four academic children's hospitals have joined forces to create a research collaborative that will make it easier for their patients to access immunotherapy clinical trials and for their researchers to find good candidates for therapies.

READ MORE

 

BC Children’s Hospital joins international collaborative to further the development of innovative immunotherapy treatments for kids with hard-to-treat cancer

Vancouver, BC — BC Children’s Hospital has joined CureWorks, an international collaborative of leading academic children’s hospitals focused on improving care for children with hard-to-treat cancers by expanding clinical trials and accelerating the development of leading-edge immunotherapy treatments.

READ MORE

 

 

NEWSROOM

Learn more about our work, our members and our commitment to curing pediatric cancer.

For press inquiries, please contact press@cureworks.org

Seattle Children’s launches into solid tumor treatments with new CAR T immunotherapy trial

Seattle Children’s Research Institute is launching a clinical trial that will examine a new kind of cancer-fighting treatment. The treatment is a type of CAR T immunotherapy, which reprograms a person’s immune cells to find and destroy cancer.

READ MORE

 

Seattle Children’s launches CureWorks, a project aimed at revolutionizing cancer treatment for kids

New cancer immunotherapies could revolutionize how we treat the disease, but for many children, those treatments are far out of reach.

READ MORE

 

Seattle Children's Hospital launches immunotherapy collaborative to expand clinical trial access at children's hospitals

Four academic children's hospitals have joined forces to create a research collaborative that will make it easier for their patients to access immunotherapy clinical trials and for their researchers to find good candidates for therapies.

READ MORE

 

BC Children’s Hospital joins international collaborative to further the development of innovative immunotherapy treatments for kids with hard-to-treat cancer

Vancouver, BC — BC Children’s Hospital has joined CureWorks, an international collaborative of leading academic children’s hospitals focused on improving care for children with hard-to-treat cancers by expanding clinical trials and accelerating the development of leading-edge immunotherapy treatments.

READ MORE

 

 

For information about clinical trials in your area, please contact
your child’s physician or visit clinicaltrials.gov

CureWorks™ is a trademark of Seattle Children’s Healthcare System and its related and controlled organizations.
Copyright © 2018 Seattle Children’s Healthcare System.

Read the latest announcements

about our collaboration.

CureWorks logo A new way to better cures

NEWSROOM

Learn more about our work, our members and our commitment to curing pediatric cancer.

For press inquiries, please contact press@cureworks.org

Seattle Children’s launches into solid tumor treatments with new CAR T immunotherapy trial

Seattle Children’s Research Institute is launching a clinical trial that will examine a new kind of cancer-fighting treatment. The treatment is a type of CAR T immunotherapy, which reprograms a person’s immune cells to find and destroy cancer.

READ MORE

 

Seattle Children’s launches CureWorks, a project aimed at revolutionizing cancer treatment for kids

New cancer immunotherapies could revolutionize how we treat the disease, but for many children, those treatments are far out of reach.

READ MORE

 

Seattle Children's Hospital launches immunotherapy collaborative to expand clinical trial access at children's hospitals

Four academic children's hospitals have joined forces to create a research collaborative that will make it easier for their patients to access immunotherapy clinical trials and for their researchers to find good candidates for therapies.

READ MORE

 

BC Children’s Hospital joins international collaborative to further the development of innovative immunotherapy treatments for kids with hard-to-treat cancer

Vancouver, BC — BC Children’s Hospital has joined CureWorks, an international collaborative of leading academic children’s hospitals focused on improving care for children with hard-to-treat cancers by expanding clinical trials and accelerating the development of leading-edge immunotherapy treatments.

READ MORE

 

For information about clinical trials in your area, please contact your child’s physician or visit clinicaltrials.gov

Read the latest announcements

about our collaboration.

CureWorks™ is a trademark of Seattle Children’s
Healthcare System and its related and controlled organizations.
Copyright © 2018 Seattle Children’s Healthcare System.

CureWorks logo A new way to better cures

NEWSROOM

Learn more about our work, our members and our commitment to curing pediatric cancer.

For press inquiries, please contact press@cureworks.org

Seattle Children’s launches into solid tumor treatments with new CAR T immunotherapy trial

Seattle Children’s Research Institute is launching a clinical trial that will examine a new kind of cancer-fighting treatment. The treatment is a type of CAR T immunotherapy, which reprograms a person’s immune cells to find and destroy cancer.

READ MORE

 

Seattle Children’s launches CureWorks, a project aimed at revolutionizing cancer treatment for kids

New cancer immunotherapies could revolutionize how we treat the disease, but for many children, those treatments are far out of reach.

READ MORE

 

Seattle Children's Hospital launches immunotherapy collaborative to expand clinical trial access at children's hospitals

Four academic children's hospitals have joined forces to create a research collaborative that will make it easier for their patients to access immunotherapy clinical trials and for their researchers to find good candidates for therapies.

READ MORE

 

BC Children’s Hospital joins international collaborative to further the development of innovative immunotherapy treatments for kids with hard-to-treat cancer

Vancouver, BC — BC Children’s Hospital has joined CureWorks, an international collaborative of leading academic children’s hospitals focused on improving care for children with hard-to-treat cancers by expanding clinical trials and accelerating the development of leading-edge immunotherapy treatments.

READ MORE

 

For information about clinical trials in your area, please contact your child’s physician or visit clinicaltrials.gov

Read the latest announcements

about our collaboration.

CureWorks™ is a trademark of Seattle Children’s
Healthcare System and its related and controlled organizations.
Copyright © 2018 Seattle Children’s Healthcare System.

For information about clinical trials in your area, please contact your child’s physician or visit clinicaltrials.gov

Read the latest announcements

about our collaboration.

CureWorks™ is a trademark of Seattle Children’s
Healthcare System and its related and controlled organizations.
Copyright © 2018 Seattle Children’s Healthcare System.

CureWorks logo A new way to better cures

NEWSROOM

Learn more about our work, our members and our commitment to curing pediatric cancer.

For press inquiries, please contact press@cureworks.org

Seattle Children’s launches into solid tumor treatments with new CAR T immunotherapy trial

Seattle Children’s Research Institute is launching a clinical trial that will examine a new kind of cancer-fighting treatment. The treatment is a type of CAR T immunotherapy, which reprograms a person’s immune cells to find and destroy cancer.

READ MORE

 

Seattle Children's Hospital launches immunotherapy collaborative to expand clinical trial access at children's hospitals

Four academic children's hospitals have joined forces to create a research collaborative that will make it easier for their patients to access immunotherapy clinical trials and for their researchers to find good candidates for therapies.

READ MORE

 

BC Children’s Hospital joins international collaborative to further the development of innovative immunotherapy treatments for kids with hard-to-treat cancer

Vancouver, BC — BC Children’s Hospital has joined CureWorks, an international collaborative of leading academic children’s hospitals focused on improving care for children with hard-to-treat cancers by expanding clinical trials and accelerating the development of leading-edge immunotherapy treatments.

READ MORE

 

BC Children’s Hospital joins international collaborative to further the development of innovative immunotherapy treatments for kids with hard-to-treat cancer

Vancouver, BC — BC Children’s Hospital has joined CureWorks, an international collaborative of leading academic children’s hospitals focused on improving care for children with hard-to-treat cancers by expanding clinical trials and accelerating the development of leading-edge immunotherapy treatments.

READ MORE

For information about clinical trials in your area, please contact
your child’s physician or visit clinicaltrials.gov

Read the latest announcements

about our collaboration.

CureWorks™ is a trademark of Seattle Children’s Healthcare System and its related and controlled organizations.
Copyright © 2018 Seattle Children’s Healthcare System.